ISPC Profile
iSpecimen Inc. is a leading technology company specializing in connecting life science researchers with human biofluids, tissues, and living cells necessary for their research. The company leverages its advanced cloud-based platform to facilitate the search and acquisition of biospecimens from a vast network of healthcare provider organizations, including hospitals, laboratories, biobanks, and blood centers. This integration streamlines the process of obtaining critical biological samples, supporting a wide range of scientific and medical research endeavors.
Central to iSpecimen's offerings is the iSpecimen Marketplace, a proprietary online platform designed to bridge the gap between researchers and biospecimen providers. The marketplace enables medical researchers to access a broad array of specimens and data, connecting them with hospitals, laboratories, and other healthcare organizations that hold these valuable resources. This innovative platform enhances the efficiency and accessibility of biospecimen procurement, facilitating faster and more targeted research.
iSpecimen serves a diverse clientele, including biopharmaceutical companies, in vitro diagnostic firms, and government and academic institutions. The company’s technology supports a wide range of research applications, from drug development and diagnostic testing to clinical trials and academic studies. By providing a streamlined, transparent, and efficient means of acquiring biological samples, iSpecimen plays a crucial role in advancing scientific knowledge and innovation.
Founded in 2009 and headquartered in Lexington, Massachusetts, iSpecimen has established itself as a key player in the biospecimen procurement sector. The company’s commitment to leveraging technology to improve access to critical research materials positions it as a vital partner for researchers and healthcare organizations worldwide. Through its ongoing innovation and comprehensive platform, iSpecimen continues to drive advancements in life science research and contribute to the broader scientific community.
|
